CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 53 enrolled
Drug / intervention
Restylane Vital Skinboosters Lidocainedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02403986
NCT02403986Phase 4Completed
CompareCT.gov

A Randomised, Multi-centre, Parallel-group, Efficacy and Safety Study Evaluating Two and Three Initial Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face

Galderma R&D·interventional·Posted Mar 31, 2015·Updated Aug 26, 2022

In Brief

A Phase 4 clinical trial evaluating Restylane Vital Skinboosters Lidocaine for Aged Skin. Completed, enrolled 53 participants across 1 site.

Detailed Summary

A randomised, multi-centre, parallel-group efficacy and safety study evaluating two and three initial treatment sessions of Restylane Skinboosters Vital Lidocaine in the face.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAged Skin
CountriesGermany
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 31, 2015
Enrollment StartApr 1, 2015
Primary CompletionMar 30, 2017
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 11.3 years ago

Interventions

Restylane Vital Skinboosters Lidocainedevice